Here are three things to know:
1. Before founding SpinalCyte, Mr. O’Heeron founded and remains the CEO of Advanced Medical Technologies, an operational investment group, which identifies early stage opportunities with strong intellectual property potential in the medical field. He remains CEO today.
2. He also founded NeoSurg Technologies, which launched the T2000 Minimally Invasive Access System under his leadership.
3. He holds 11 patents and currently has 63 patents pending.
More articles on biologics:
RTI Surgical & Aziyo Biologics ink deal: 4 things to know
Asterias Biotherapeutics’ stem cell-derived treatment for spinal cord injury holds promise: 4 things to know
Ortho RTi receives extension on 2.1M+ warrants: 3 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
